These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 35966797)
1. Associations of multiple visual rating scales based on structural magnetic resonance imaging with disease severity and cerebrospinal fluid biomarkers in patients with Alzheimer's disease. Wan MD; Liu H; Liu XX; Zhang WW; Xiao XW; Zhang SZ; Jiang YL; Zhou H; Liao XX; Zhou YF; Tang BS; Wang JL; Guo JF; Jiao B; Shen L Front Aging Neurosci; 2022; 14():906519. PubMed ID: 35966797 [TBL] [Abstract][Full Text] [Related]
2. Characteristics of Cortical Atrophy and White Matter Lesions Between Dementia With Lewy Bodies and Alzheimer's Disease: A Case-Control Study. Zhu H; Lu H; Wang F; Liu S; Shi Z; Gan J; Du X; Yang Y; Li D; Wang L; Ji Y Front Neurol; 2021; 12():779344. PubMed ID: 35087466 [No Abstract] [Full Text] [Related]
3. Practical cut-offs for visual rating scales of medial temporal, frontal and posterior atrophy in Alzheimer's disease and mild cognitive impairment. Ferreira D; Cavallin L; Larsson EM; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Lovestone S; Simmons A; Wahlund LO; Westman E; J Intern Med; 2015 Sep; 278(3):277-90. PubMed ID: 25752192 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of MR Visual Rating Scales in Major Forms of Dementia. Kaushik S; Vani K; Chumber S; Anand KS; Dhamija RK J Neurosci Rural Pract; 2021 Jan; 12(1):16-23. PubMed ID: 33531755 [No Abstract] [Full Text] [Related]
5. Combining visual rating scales to identify prodromal Alzheimer's disease and Alzheimer's disease dementia in a population from a low and middle-income country. Custodio N; Malaga M; Chambergo-Michilot D; Montesinos R; Moron E; Vences MA; Huilca JC; Lira D; Failoc-Rojas VE; Diaz MM Front Neurol; 2022; 13():962192. PubMed ID: 36119675 [TBL] [Abstract][Full Text] [Related]
6. Automatically computed rating scales from MRI for patients with cognitive disorders. Koikkalainen JR; Rhodius-Meester HFM; Frederiksen KS; Bruun M; Hasselbalch SG; Baroni M; Mecocci P; Vanninen R; Remes A; Soininen H; van Gils M; van der Flier WM; Scheltens P; Barkhof F; Erkinjuntti T; Lötjönen JMP; Eur Radiol; 2019 Sep; 29(9):4937-4947. PubMed ID: 30796570 [TBL] [Abstract][Full Text] [Related]
7. [Correlation of muscle strength with cognitive function and medial temporal lobe atrophy in patients with mild to moderate Alzheimer's disease]. Liu SW; Li M; Zhu JT; Zhang YC; Wu YH; Liu CF; Hu H Zhonghua Yi Xue Za Zhi; 2022 Sep; 102(35):2786-2792. PubMed ID: 36124351 [No Abstract] [Full Text] [Related]
8. Relationship Between General Cognition, Visual Assessed Cortical Atrophy, and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease: A Cross-Sectional Study from a Chinese PUMCH Cohort. Mao C; Sha L; Li J; Huang X; Chu S; Lei D; Wang J; Dong L; Liu C; Xu Q; Peng B; Gao J J Alzheimers Dis; 2021; 82(1):205-214. PubMed ID: 34024840 [TBL] [Abstract][Full Text] [Related]
9. Correlation of Frontal Atrophy and CSF Tau Levels With Neuropsychiatric Symptoms in Patients With Cognitive Impairment: A Memory Clinic Experience. Cotta Ramusino M; Perini G; Vaghi G; Dal Fabbro B; Capelli M; Picascia M; Franciotta D; Farina L; Ballante E; Costa A Front Aging Neurosci; 2021; 13():595758. PubMed ID: 33746732 [No Abstract] [Full Text] [Related]
10. Multiple Visual Rating Scales Based on Structural MRI and a Novel Prediction Model Combining Visual Rating Scales and Age Stratification in the Diagnosis of Alzheimer's Disease in the Chinese Population. Yuan Z; Pan C; Xiao T; Liu M; Zhang W; Jiao B; Yan X; Tang B; Shen L Front Neurol; 2019; 10():93. PubMed ID: 30842751 [No Abstract] [Full Text] [Related]
11. A new age-related cutoff of medial temporal atrophy scale on MRI improving the diagnostic accuracy of neurodegeneration due to Alzheimer's disease in a Chinese population. Wei M; Shi J; Ni J; Zhang X; Li T; Chen Z; Zhou M; Zhang L; Tan Z; Wang Y; Tian J BMC Geriatr; 2019 Feb; 19(1):59. PubMed ID: 30819102 [TBL] [Abstract][Full Text] [Related]
12. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets. Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL; Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169 [TBL] [Abstract][Full Text] [Related]
13. Regional atrophy is associated with impairment in distinct cognitive domains in Alzheimer's disease. Smits LL; Tijms BM; Benedictus MR; Koedam EL; Koene T; Reuling IE; Barkhof F; Scheltens P; Pijnenburg YA; Wattjes MP; van der Flier WM Alzheimers Dement; 2014 Oct; 10(5 Suppl):S299-305. PubMed ID: 24210526 [TBL] [Abstract][Full Text] [Related]
15. Evaluation and clinical correlation of practical cut-offs for visual rating scales of atrophy: normal aging versus mild cognitive impairment and Alzheimer's disease. Vanhoenacker AS; Sneyers B; De Keyzer F; Heye S; Demaerel P Acta Neurol Belg; 2017 Sep; 117(3):661-669. PubMed ID: 28397182 [TBL] [Abstract][Full Text] [Related]
16. Combining Visual Rating Scales for Medial Temporal Lobe Atrophy and Posterior Atrophy to Identify Amnestic Mild Cognitive Impairment from Cognitively Normal Older Adults: Evidence Based on Two Cohorts. Sheng C; Sun Y; Wang M; Wang X; Liu Y; Pang D; Liu J; Bi X; Du W; Zhao M; Li Y; Li X; Jiang J; Han Y J Alzheimers Dis; 2020; 77(1):323-337. PubMed ID: 32716355 [TBL] [Abstract][Full Text] [Related]
17. Posterior Atrophy and Medial Temporal Atrophy Scores Are Associated with Different Symptoms in Patients with Alzheimer's Disease and Mild Cognitive Impairment. Hsu JL; Lee WJ; Liao YC; Lirng JF; Wang SJ; Fuh JL PLoS One; 2015; 10(9):e0137121. PubMed ID: 26372372 [TBL] [Abstract][Full Text] [Related]
18. Diurnal cortisol, neuroinflammation, and neuroimaging visual rating scales in memory clinic patients. Holleman J; Daniilidou M; Kåreholt I; Aspö M; Hagman G; Udeh-Momoh CT; Spulber G; Kivipelto M; Solomon A; Matton A; Sindi S Brain Behav Immun; 2024 May; 118():499-509. PubMed ID: 38503394 [TBL] [Abstract][Full Text] [Related]
19. The combined effect of amyloid-β and tau biomarkers on brain atrophy in dementia with Lewy bodies. Abdelnour C; Ferreira D; Oppedal K; Cavallin L; Bousiges O; Wahlund LO; Hort J; Nedelska Z; Padovani A; Pilotto A; Bonanni L; Kramberger MG; Boada M; Westman E; Pagonabarraga J; Kulisevsky J; Blanc F; Aarsland D Neuroimage Clin; 2020; 27():102333. PubMed ID: 32674011 [TBL] [Abstract][Full Text] [Related]
20. The usefulness of visual rating of posterior atrophy in predicting rapid cognitive decline in Alzheimer disease: A preliminary study. Suh J; Park YH; Kim HR; Jang JW; Kang MJ; Yang J; Baek MJ; Kim S Int J Geriatr Psychiatry; 2019 Apr; 34(4):625-632. PubMed ID: 30714196 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]